Global Parkinson's Disease Drug Market Professional Survey Report 2017

October 2017 | 119 pages | ID: G8780F6A146PEN
QYResearch

Abstracts

This report studies Parkinson's Disease Drug in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Merck
• Akorn
• GSK
• Novartis
• Boehringer Ingelheim
• Teva Pharmaceutical
• Abbvie
• Kyowa Hakko Kirin Pharma
• Astellas Pharma
• Desitin Arzneimittel
• Endo Pharmaceuticals
• F.Hoffmann-La Roche
• H.Lundbeck
• Valeant
• Apokyn
• Orion
• Stada Arzneimittel
• US WorldMeds
• Valeant Pharmaceuticals

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Sinemet-CR
• Trastal
• Madopar
• COMT Inhibitor
• Other

By Application, the market can be split into

• Under 40 Years Old
• 40-65 Years Old
• Above 65 Years Old

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Parkinson's Disease Drug Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF PARKINSON'S DISEASE DRUG

1.1 Definition and Specifications of Parkinson's Disease Drug
  1.1.1 Definition of Parkinson's Disease Drug
  1.1.2 Specifications of Parkinson's Disease Drug
1.2 Classification of Parkinson's Disease Drug
  1.2.1 Sinemet-CR
  1.2.2 Trastal
  1.2.3 Madopar
  1.2.4 COMT Inhibitor
  1.2.5 Other
1.3 Applications of Parkinson's Disease Drug
  1.3.1 Under 40 Years Old
  1.3.2 40-65 Years Old
  1.3.3 Above 65 Years Old
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF PARKINSON'S DISEASE DRUG

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Parkinson's Disease Drug
2.3 Manufacturing Process Analysis of Parkinson's Disease Drug
2.4 Industry Chain Structure of Parkinson's Disease Drug

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF PARKINSON'S DISEASE DRUG

3.1 Capacity and Commercial Production Date of Global Parkinson's Disease Drug Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Parkinson's Disease Drug Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Parkinson's Disease Drug Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Parkinson's Disease Drug Major Manufacturers in 2016

4 GLOBAL PARKINSON'S DISEASE DRUG OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global Parkinson's Disease Drug Capacity and Growth Rate Analysis
  4.2.2 2016 Parkinson's Disease Drug Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global Parkinson's Disease Drug Sales and Growth Rate Analysis
  4.3.2 2016 Parkinson's Disease Drug Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global Parkinson's Disease Drug Sales Price
  4.4.2 2016 Parkinson's Disease Drug Sales Price Analysis (Company Segment)

5 PARKINSON'S DISEASE DRUG REGIONAL MARKET ANALYSIS

5.1 North America Parkinson's Disease Drug Market Analysis
  5.1.1 North America Parkinson's Disease Drug Market Overview
  5.1.2 North America 2012-2017E Parkinson's Disease Drug Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E Parkinson's Disease Drug Sales Price Analysis
  5.1.4 North America 2016 Parkinson's Disease Drug Market Share Analysis
5.2 China Parkinson's Disease Drug Market Analysis
  5.2.1 China Parkinson's Disease Drug Market Overview
  5.2.2 China 2012-2017E Parkinson's Disease Drug Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E Parkinson's Disease Drug Sales Price Analysis
  5.2.4 China 2016 Parkinson's Disease Drug Market Share Analysis
5.3 Europe Parkinson's Disease Drug Market Analysis
  5.3.1 Europe Parkinson's Disease Drug Market Overview
  5.3.2 Europe 2012-2017E Parkinson's Disease Drug Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E Parkinson's Disease Drug Sales Price Analysis
  5.3.4 Europe 2016 Parkinson's Disease Drug Market Share Analysis
5.4 Southeast Asia Parkinson's Disease Drug Market Analysis
  5.4.1 Southeast Asia Parkinson's Disease Drug Market Overview
  5.4.2 Southeast Asia 2012-2017E Parkinson's Disease Drug Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E Parkinson's Disease Drug Sales Price Analysis
  5.4.4 Southeast Asia 2016 Parkinson's Disease Drug Market Share Analysis
5.5 Japan Parkinson's Disease Drug Market Analysis
  5.5.1 Japan Parkinson's Disease Drug Market Overview
  5.5.2 Japan 2012-2017E Parkinson's Disease Drug Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E Parkinson's Disease Drug Sales Price Analysis
  5.5.4 Japan 2016 Parkinson's Disease Drug Market Share Analysis
5.6 India Parkinson's Disease Drug Market Analysis
  5.6.1 India Parkinson's Disease Drug Market Overview
  5.6.2 India 2012-2017E Parkinson's Disease Drug Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E Parkinson's Disease Drug Sales Price Analysis
  5.6.4 India 2016 Parkinson's Disease Drug Market Share Analysis

6 GLOBAL 2012-2017E PARKINSON'S DISEASE DRUG SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E Parkinson's Disease Drug Sales by Type
6.2 Different Types of Parkinson's Disease Drug Product Interview Price Analysis
6.3 Different Types of Parkinson's Disease Drug Product Driving Factors Analysis
  6.3.1 Sinemet-CR of Parkinson's Disease Drug Growth Driving Factor Analysis
  6.3.2 Trastal of Parkinson's Disease Drug Growth Driving Factor Analysis
  6.3.3 Madopar of Parkinson's Disease Drug Growth Driving Factor Analysis
  6.3.4 COMT Inhibitor of Parkinson's Disease Drug Growth Driving Factor Analysis
  6.3.5 Other of Parkinson's Disease Drug Growth Driving Factor Analysis

7 GLOBAL 2012-2017E PARKINSON'S DISEASE DRUG SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E Parkinson's Disease Drug Consumption by Application
7.2 Different Application of Parkinson's Disease Drug Product Interview Price Analysis
7.3 Different Application of Parkinson's Disease Drug Product Driving Factors Analysis
  7.3.1 Under 40 Years Old of Parkinson's Disease Drug Growth Driving Factor Analysis
  7.3.2 40-65 Years Old of Parkinson's Disease Drug Growth Driving Factor Analysis
  7.3.3 Above 65 Years Old of Parkinson's Disease Drug Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF PARKINSON'S DISEASE DRUG

8.1 Merck
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Merck 2016 Parkinson's Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Merck 2016 Parkinson's Disease Drug Business Region Distribution Analysis
8.2 Akorn
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Akorn 2016 Parkinson's Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Akorn 2016 Parkinson's Disease Drug Business Region Distribution Analysis
8.3 GSK
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 GSK 2016 Parkinson's Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 GSK 2016 Parkinson's Disease Drug Business Region Distribution Analysis
8.4 Novartis
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Novartis 2016 Parkinson's Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Novartis 2016 Parkinson's Disease Drug Business Region Distribution Analysis
8.5 Boehringer Ingelheim
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Boehringer Ingelheim 2016 Parkinson's Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Boehringer Ingelheim 2016 Parkinson's Disease Drug Business Region Distribution Analysis
8.6 Teva Pharmaceutical
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Teva Pharmaceutical 2016 Parkinson's Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Teva Pharmaceutical 2016 Parkinson's Disease Drug Business Region Distribution Analysis
8.7 Abbvie
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Abbvie 2016 Parkinson's Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Abbvie 2016 Parkinson's Disease Drug Business Region Distribution Analysis
8.8 Kyowa Hakko Kirin Pharma
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Kyowa Hakko Kirin Pharma 2016 Parkinson's Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Kyowa Hakko Kirin Pharma 2016 Parkinson's Disease Drug Business Region Distribution Analysis
8.9 Astellas Pharma
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 Astellas Pharma 2016 Parkinson's Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Astellas Pharma 2016 Parkinson's Disease Drug Business Region Distribution Analysis
8.10 Desitin Arzneimittel
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Product A
    8.10.2.2 Product B
  8.10.3 Desitin Arzneimittel 2016 Parkinson's Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 Desitin Arzneimittel 2016 Parkinson's Disease Drug Business Region Distribution Analysis
8.11 Endo Pharmaceuticals
8.12 F.Hoffmann-La Roche
8.13 H.Lundbeck
8.14 Valeant
8.15 Apokyn
8.16 Orion
8.17 Stada Arzneimittel
8.18 US WorldMeds
8.19 Valeant Pharmaceuticals

9 DEVELOPMENT TREND OF ANALYSIS OF PARKINSON'S DISEASE DRUG MARKET

9.1 Global Parkinson's Disease Drug Market Trend Analysis
  9.1.1 Global 2017-2022 Parkinson's Disease Drug Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Parkinson's Disease Drug Sales Price Forecast
9.2 Parkinson's Disease Drug Regional Market Trend
  9.2.1 North America 2017-2022 Parkinson's Disease Drug Consumption Forecast
  9.2.2 China 2017-2022 Parkinson's Disease Drug Consumption Forecast
  9.2.3 Europe 2017-2022 Parkinson's Disease Drug Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Parkinson's Disease Drug Consumption Forecast
  9.2.5 Japan 2017-2022 Parkinson's Disease Drug Consumption Forecast
  9.2.6 India 2017-2022 Parkinson's Disease Drug Consumption Forecast
9.3 Parkinson's Disease Drug Market Trend (Product Type)
9.4 Parkinson's Disease Drug Market Trend (Application)

10 PARKINSON'S DISEASE DRUG MARKETING TYPE ANALYSIS

10.1 Parkinson's Disease Drug Regional Marketing Type Analysis
10.2 Parkinson's Disease Drug International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Parkinson's Disease Drug by Region
10.4 Parkinson's Disease Drug Supply Chain Analysis

11 CONSUMERS ANALYSIS OF PARKINSON'S DISEASE DRUG

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL PARKINSON'S DISEASE DRUG MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Parkinson's Disease Drug
Table Product Specifications of Parkinson's Disease Drug
Table Classification of Parkinson's Disease Drug
Figure Global Production Market Share of Parkinson's Disease Drug by Type in 2016
Figure Sinemet-CR Picture
Table Major Manufacturers of Sinemet-CR
Figure Trastal Picture
Table Major Manufacturers of Trastal
Figure Madopar Picture
Table Major Manufacturers of Madopar
Figure COMT Inhibitor Picture
Table Major Manufacturers of COMT Inhibitor
Figure Other Picture
Table Major Manufacturers of Other
Table Applications of Parkinson's Disease Drug
Figure Global Consumption Volume Market Share of Parkinson's Disease Drug by Application in 2016
Figure Under 40 Years Old Examples
Table Major Consumers in Under 40 Years Old
Figure 40-65 Years Old Examples
Table Major Consumers in 40-65 Years Old
Figure Above 65 Years Old Examples
Table Major Consumers in Above 65 Years Old
Figure Market Share of Parkinson's Disease Drug by Regions
Figure North America Parkinson's Disease Drug Market Size (Million USD) (2012-2022)
Figure China Parkinson's Disease Drug Market Size (Million USD) (2012-2022)
Figure Europe Parkinson's Disease Drug Market Size (Million USD) (2012-2022)
Figure Southeast Asia Parkinson's Disease Drug Market Size (Million USD) (2012-2022)
Figure Japan Parkinson's Disease Drug Market Size (Million USD) (2012-2022)
Figure India Parkinson's Disease Drug Market Size (Million USD) (2012-2022)
Table Parkinson's Disease Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Parkinson's Disease Drug in 2016
Figure Manufacturing Process Analysis of Parkinson's Disease Drug
Figure Industry Chain Structure of Parkinson's Disease Drug
Table Capacity and Commercial Production Date of Global Parkinson's Disease Drug Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Parkinson's Disease Drug Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Parkinson's Disease Drug Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Parkinson's Disease Drug Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Parkinson's Disease Drug 2012-2017
Figure Global 2012-2017E Parkinson's Disease Drug Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Parkinson's Disease Drug Market Size (Value) and Growth Rate
Table 2012-2017E Global Parkinson's Disease Drug Capacity and Growth Rate
Table 2016 Global Parkinson's Disease Drug Capacity (K Units) List (Company Segment)
Table 2012-2017E Global Parkinson's Disease Drug Sales (K Units) and Growth Rate
Table 2016 Global Parkinson's Disease Drug Sales (K Units) List (Company Segment)
Table 2012-2017E Global Parkinson's Disease Drug Sales Price (USD/Unit)
Table 2016 Global Parkinson's Disease Drug Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of Parkinson's Disease Drug 2012-2017E
Figure North America 2012-2017E Parkinson's Disease Drug Sales Price (USD/Unit)
Figure North America 2016 Parkinson's Disease Drug Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of Parkinson's Disease Drug 2012-2017E
Figure China 2012-2017E Parkinson's Disease Drug Sales Price (USD/Unit)
Figure China 2016 Parkinson's Disease Drug Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of Parkinson's Disease Drug 2012-2017E
Figure Europe 2012-2017E Parkinson's Disease Drug Sales Price (USD/Unit)
Figure Europe 2016 Parkinson's Disease Drug Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Parkinson's Disease Drug 2012-2017E
Figure Southeast Asia 2012-2017E Parkinson's Disease Drug Sales Price (USD/Unit)
Figure Southeast Asia 2016 Parkinson's Disease Drug Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of Parkinson's Disease Drug 2012-2017E
Figure Japan 2012-2017E Parkinson's Disease Drug Sales Price (USD/Unit)
Figure Japan 2016 Parkinson's Disease Drug Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of Parkinson's Disease Drug 2012-2017E
Figure India 2012-2017E Parkinson's Disease Drug Sales Price (USD/Unit)
Figure India 2016 Parkinson's Disease Drug Sales Market Share
Table Global 2012-2017E Parkinson's Disease Drug Sales (K Units) by Type
Table Different Types Parkinson's Disease Drug Product Interview Price
Table Global 2012-2017E Parkinson's Disease Drug Sales (K Units) by Application
Table Different Application Parkinson's Disease Drug Product Interview Price
Table Merck Information List
Table Product A Overview
Table Product B Overview
Table 2016 Merck Parkinson's Disease Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Merck Parkinson's Disease Drug Business Region Distribution
Table Akorn Information List
Table Product A Overview
Table Product B Overview
Table 2016 Akorn Parkinson's Disease Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Akorn Parkinson's Disease Drug Business Region Distribution
Table GSK Information List
Table Product A Overview
Table Product B Overview
Table 2015 GSK Parkinson's Disease Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 GSK Parkinson's Disease Drug Business Region Distribution
Table Novartis Information List
Table Product A Overview
Table Product B Overview
Table 2016 Novartis Parkinson's Disease Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Novartis Parkinson's Disease Drug Business Region Distribution
Table Boehringer Ingelheim Information List
Table Product A Overview
Table Product B Overview
Table 2016 Boehringer Ingelheim Parkinson's Disease Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Boehringer Ingelheim Parkinson's Disease Drug Business Region Distribution
Table Teva Pharmaceutical Information List
Table Product A Overview
Table Product B Overview
Table 2016 Teva Pharmaceutical Parkinson's Disease Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Teva Pharmaceutical Parkinson's Disease Drug Business Region Distribution
Table Abbvie Information List
Table Product A Overview
Table Product B Overview
Table 2016 Abbvie Parkinson's Disease Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Abbvie Parkinson's Disease Drug Business Region Distribution
Table Kyowa Hakko Kirin Pharma Information List
Table Product A Overview
Table Product B Overview
Table 2016 Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Business Region Distribution
Table Astellas Pharma Information List
Table Product A Overview
Table Product B Overview
Table 2016 Astellas Pharma Parkinson's Disease Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Astellas Pharma Parkinson's Disease Drug Business Region Distribution
Table Desitin Arzneimittel Information List
Table Product A Overview
Table Product B Overview
Table 2016 Desitin Arzneimittel Parkinson's Disease Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Desitin Arzneimittel Parkinson's Disease Drug Business Region Distribution
Table Endo Pharmaceuticals Information List
Table F.Hoffmann-La Roche Information List
Table H.Lundbeck Information List
Table Valeant Information List
Table Apokyn Information List
Table Orion Information List
Table Stada Arzneimittel Information List
Table US WorldMeds Information List
Table Valeant Pharmaceuticals Information List
Figure Global 2017-2022 Parkinson's Disease Drug Market Size (K Units) and Growth Rate Forecast
Figure Global 2017-2022 Parkinson's Disease Drug Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Parkinson's Disease Drug Sales Price (USD/Unit) Forecast
Figure North America 2017-2022 Parkinson's Disease Drug Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2017-2022 Parkinson's Disease Drug Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2017-2022 Parkinson's Disease Drug Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Parkinson's Disease Drug Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2017-2022 Parkinson's Disease Drug Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2017-2022 Parkinson's Disease Drug Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of Parkinson's Disease Drug by Type 2017-2022
Table Global Consumption Volume (K Units) of Parkinson's Disease Drug by Application 2017-2022
Table Traders or Distributors with Contact Information of Parkinson's Disease Drug by Region